# Spero Therapeutics, Inc. (SPRO)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/SPRO/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 258.0K | $ -16.76M | $ 10.51M | $ 2.04M | $ 44.20M |
| 2025 | $ 61.83M | $ 8.78M | $ -12.93M | $ 2.90M | $ 59.02M |
| 2024 | $ 45.11M | $ -72.07M | $ -24.64M | $ 4.30M | $ 46.12M |
| 2023 | $ 112.21M | $ 24.66M | $ -35.68M | $ 5.54M | $ 106.89M |
| 2022 | $ 54.27M | $ -51.85M | $ -8.78M | $ 6.65M | $ 75.93M |
| 2021 | $ 15.28M | $ -106.69M | $ -76.49M | $ 7.34M | $ 88.29M |
| 2020 | $ 11.89M | $ -99.72M | $ -109.59M | $ 7.84M | $ 132.04M |
| 2019 | $ 12.60M | $ -78.64M | $ -64.97M | $ 5.55M | $ 74.57M |
| 2018 | $ 5.24M | $ -55.02M | $ -55.52M | $ 0 | $ 115.86M |
| 2017 | $ 2.67M | $ -53.42M | $ -52.72M | $ 0 | $ 84.96M |
| 2016 | $ 460.9K | $ -18.61M | $ -22.30M | $ 0 | $ 10.17M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.05 |
| Liabilities / Eq | 0.19 |
| Current Ratio | 6.12 |

## Other views

- [Metrics](https://sponda.capital/en/SPRO.md)
- [Charts](https://sponda.capital/en/SPRO/charts.md)
- [Compare](https://sponda.capital/en/SPRO/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.